[Effects of octapressin on the general and coronary circulation in anesthetized, closed chest dogs].
D000818:Animals; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D002320:Cardiovascular Physiological Phenomena; D003331:Coronary Vessels / Q000187:drug effects* / Q000502:physiology; D004285:Dogs; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D007275:Injections, Intravenous; D008239:Lysine / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D010649:Phenylalanine / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects*; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014667:Vasopressins / Q000494:pharmacology*
D014662:Vasoconstrictor Agents; D014667:Vasopressins; D010649:Phenylalanine; D008239:Lysine
Koronar- und allgemeine Kreislaufwirkungen von Octapressin (Phenylalanin-Lysin-Vasopressin) am intakten, narkotisierten Hund.